GER Equity Snapshot

FYB Weekly Equity Report

Formycon AG

Interactive chart JSON snapshot
Latest Close 20.55 EUR 12 Jun 2026
1W Return -0.5% latest completed week
4W Return 8.8% short-term follow-through
12W Return 20.5% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
Company Brief

What the company does

Formycon AG, a biotechnology company, develops biosimilar drugs in Germany and Switzerland. It provides ranibizumab and aflibercept used in the treatment of neovascular age-related macular degeneration, diabetic macular edema, choroidal neovascularization, proliferative diabetic retinopathy, and macular edema under the Ranivisio, Ongavia, Cimerli, Ranopto, Uptera, and Ravegza brand names, as well as AHZANTIVE, Baiama, and Fovlya brand names. The company's pipeline includes ustekinumab used in the treatment of Crohn's disease, ulcerative colitis, Plaque Psoriasis, and Psoriatic Arthritis under the Otulf, Fymskina, and Sitovab brand names. It is also developing pembrolizumab for the treatment of immuno-oncology diseases, …

Snapshot

What the weekly tape is saying

FYB closed the latest completed week at 20.55 EUR. The 4-week return is 8.8% and the 12-week return is 20.5%. Trend Signal is inactive, Market Dynamics is 0.53. Setup signature: Risk-first tape with a 34/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -4.8%
Volume 0.6x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 0 Persistence of active Trend Signal over the last year and current streak.
Momentum 89 Blend of 4-week and 12-week follow-through.
Dynamics 74 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 15 Relative leadership and short-term RS change.
Volume 25 Participation compared with the 13-week volume baseline.
Risk Control 0 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
21.58 EUR
Vs Trend Line
-4.8%
Fair Value
39.97 EUR
Vs Fair Value
-48.6%
52W High
31.30 EUR
52W Low
15.80 EUR
Drawdown
-34.3%
Range Position
30.6%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -0.5%
4W 8.8%
12W 20.5%
26W -13.1%
52W -24.3%

Trend read

Active Streak
0 weeks
52W Active Weeks
0
52W Active Breadth
0.0%
Sector Scope
DE Healthcare
Sector Rank
30 of 80
Sector Percentile
63.3%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
0.53
4W MD Change
183.3%
Relative Strength
-12.56
4W RS Change
32.7%
Expectation
Negative
Probability
43.40%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
36.0K
13W Average
60.8K
52W Average
83.9K
Vs 13W
0.6x
Vs 52W
0.4x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
7.0%
52W Volatility
6.1%
Upside Weeks
21
Downside Weeks
29
Downside Breadth
55.8%
Avg Gain / Loss
5.5% / -4.6%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
GER
Country
DE
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Market Cap
399.4M

Opportunity signals

  • Market Dynamics is positive on the latest completed week.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 20.55 EUR -0.5% 21.58 EUR 39.97 EUR 0.53 -12.56 36.0K Off
5 Jun 2026 20.65 EUR -8.6% 21.58 EUR 40.27 EUR 0.28 -13.13 38.8K Off
29 May 2026 22.60 EUR 12.7% 21.57 EUR 40.59 EUR 0.09 -6.70 81.5K Off
22 May 2026 20.05 EUR 6.2% 21.55 EUR 40.91 EUR -0.38 -16.65 68.0K Off
15 May 2026 18.88 EUR 0.4% 21.63 EUR 41.27 EUR -0.63 -18.66 35.4K Off
8 May 2026 18.80 EUR 3.9% 21.78 EUR 41.65 EUR -0.68 -20.57 74.3K Off
1 May 2026 18.10 EUR -1.1% 21.97 EUR 41.96 EUR -0.92 -23.78 24.7K Off
24 Apr 2026 18.30 EUR -7.7% 22.21 EUR 42.30 EUR -1.00 -22.81 57.6K Off
17 Apr 2026 19.82 EUR 11.9% 22.34 EUR 42.63 EUR -0.99 -18.76 70.6K Off
10 Apr 2026 17.72 EUR -4.8% 22.46 EUR 42.92 EUR -1.04 -25.03 47.9K Off
3 Apr 2026 18.62 EUR 5.4% 22.61 EUR 43.24 EUR -0.95 -19.56 25.1K Off
27 Mar 2026 17.66 EUR 3.5% 22.77 EUR 43.54 EUR -0.86 -21.20 114.7K Off
20 Mar 2026 17.06 EUR -9.6% 22.99 EUR 43.85 EUR -0.59 -24.53 115.7K Off
13 Mar 2026 18.88 EUR -4.4% 23.23 EUR 44.17 EUR -0.32 -20.89 94.7K Off